Cambridge, United Kingdom · Founded 2017 · Privately Held (backing)
Operator of a biotechnology company intended to develop simulation-guided cell rejuvenation therapies to address the diseases of aging. Shift Bioscience is based in Cambridge, United Kingdom and was founded in 2017. Its last known valuation is $30.5 million. It has raised $17.5 million.
Last price · $/share
—
Implied valuation
$30.5M
Total raised
$17.5M
Last round
—
Team — not yet on record
No current team members for Shift Bioscience are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Shift Bioscience with a free account
·The complete investor list: 13 names
·Watch Shift Bioscience: the Monday email on marks, rounds and moves
